-
公开(公告)号：US09296828B2
公开(公告)日：2016-03-29
申请号：US12304267
申请日：2007-06-11
申请人： Rudolf Valenta , Margarete Focke-Tejkl , Birgit Linhart , Susanne Vrtala , Peter Valent , Renate Reininger , Susanne Spitzauer , Ines Swoboda , Marianne Van Hage , Hans Grönlund , Johanna Tinhofer , Kerstin Westritschnig , Theresia Popow-Kraupp
发明人： Rudolf Valenta , Margarete Focke-Tejkl , Birgit Linhart , Susanne Vrtala , Peter Valent , Renate Reininger , Susanne Spitzauer , Ines Swoboda , Marianne Van Hage , Hans Grönlund , Johanna Tinhofer , Kerstin Westritschnig , Theresia Popow-Kraupp
IPC分类号： A61K38/00 , A61K39/00 , A61K39/35 , A61K39/36 , A61K39/385 , C07H21/02 , C07H21/04 , C12N15/00 , C07K19/00 , C07K14/415
CPC分类号： C07K14/415 , A61K39/35 , A61K39/36 , A61K2039/5256 , A61K2039/5258 , C07K19/00 , C12N2770/32734
摘要： The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof.
摘要翻译： 本发明涉及由至少一种衍生自变应原的低变应原分子组成的低变应原性蛋白质，其与至少一种第二非致敏性蛋白质或其片段融合或缀合。
-
公开(公告)号：US09638694B2
公开(公告)日：2017-05-02
申请号：US13504766
申请日：2010-11-02
申请人： Rudolf Valenta , Katarzyna Niespodziana , Johanna Edlmayr , Dieter Blaas , Verena Niederberger-Leppin , Nikos Papadopoulos , Theresia Popow-Kraupp
发明人： Rudolf Valenta , Katarzyna Niespodziana , Johanna Edlmayr , Dieter Blaas , Verena Niederberger-Leppin , Nikos Papadopoulos , Theresia Popow-Kraupp
IPC分类号： C12Q1/02 , C12Q1/04 , C12Q1/70 , A61K39/12 , G01N33/569
CPC分类号： G01N33/56983 , A61K39/12 , C12N2770/32734 , C12Q1/02 , C12Q1/04 , C12Q1/70 , G01N2333/095 , G01N2469/20
摘要： The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4.
-
3.发明申请Pharmaceutical composition for the treatment and prevention of a rhinovirus infection 有权用于治疗和预防鼻病毒感染的药物组合物公开(公告)号：US20120213820A1
公开(公告)日：2012-08-23
申请号：US13504766
申请日：2010-11-02
申请人： Rudolf Valenta , Katarzyna Niespodziana , Johanna Edlmayr , Dieter Blaas , Verena Niederberger-Leppin , Nikos Papadopoulos , Theresia Popow-Kraupp
发明人： Rudolf Valenta , Katarzyna Niespodziana , Johanna Edlmayr , Dieter Blaas , Verena Niederberger-Leppin , Nikos Papadopoulos , Theresia Popow-Kraupp
IPC分类号： A61K39/125 , C07K4/02 , A61P37/04 , C07K14/095 , C07K19/00 , G01N33/566 , A61P31/16 , C07K7/06
CPC分类号： G01N33/56983 , A61K39/12 , C12N2770/32734 , C12Q1/02 , C12Q1/04 , C12Q1/70 , G01N2333/095 , G01N2469/20
摘要： The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4.
摘要翻译： 本发明涉及一种药物组合物，其包含至少一种由至少8个氨基酸残基组成的肽和最多50个氨基酸残基的肽，所述氨基酸残基为选自VP1，VP2，VP3的鼻病毒衣壳蛋白 和VP4。
-
公开(公告)号：US20090324501A1
公开(公告)日：2009-12-31
申请号：US12304267
申请日：2007-06-11
申请人： Rudolf Valenta , Margarete Focke-Tejkl , Birgit Linhart , Susanne Vrtala , Peter Valent , Renat Reininger , Susanne Spitzauer , Ines Swoboda , Marianne Van Hage , Hans Grönlund , Johanna Tinhofer , Kerstin Westritschnig , Theresia Popow-Kraupp
发明人： Rudolf Valenta , Margarete Focke-Tejkl , Birgit Linhart , Susanne Vrtala , Peter Valent , Renat Reininger , Susanne Spitzauer , Ines Swoboda , Marianne Van Hage , Hans Grönlund , Johanna Tinhofer , Kerstin Westritschnig , Theresia Popow-Kraupp
IPC分类号： A61K39/35 , C07K14/00 , C07H21/04 , C07K16/00 , A61K39/395 , A61P31/12 , C07K14/415 , C12N15/63 , C12N5/10 , A61K49/00 , A61P37/08
CPC分类号： C07K14/415 , A61K39/35 , A61K39/36 , A61K2039/5256 , A61K2039/5258 , C07K19/00 , C12N2770/32734
摘要： The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof.
摘要翻译： 本发明涉及由至少一种衍生自变应原的低变应原分子组成的低变应原性蛋白质，其与至少一种第二非致敏性蛋白质或其片段融合或缀合。
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
